Sign In
Buy OPY
$106.64
-4.06 (-3.67%)
At Close: Jul 31, 2026
Ovid Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
08:00am, Wednesday, 05'th Feb 2025
NEW YORK, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (Nasdaq: OVID), a biopharmaceutical company dedicated to developing medicines for brain conditions with significant unmet need, toda
Carisma Therapeutics to Participate in Oppenheimer 35th Annual Healthcare Life Sciences Conference
07:30am, Wednesday, 05'th Feb 2025
PHILADELPHIA , Feb. 5, 2025 /PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a leader in macrophage-focused therapeutics, today announced that Steven Kelly, Presi
Jasper Therapeutics to Present at the Oppenheimer Healthcare Life Sciences Conference
04:30pm, Tuesday, 04'th Feb 2025
REDWOOD CITY, Calif., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel antibod
Q32 Bio to Participate in Oppenheimer's 35th Annual Healthcare Life Sciences Conference
04:05pm, Tuesday, 04'th Feb 2025
WALTHAM, Mass. , Feb. 4, 2025 /PRNewswire/ -- Q32 Bio Inc. (Nasdaq: QTTB) ("Q32 Bio"), a clinical stage biotechnology company focused on developing biologic therapeutics to restore immune homeostasis,
HF Foods Group Inc. to Participate in the Oppenheimer Emerging Growth Conference
04:05pm, Tuesday, 04'th Feb 2025
LAS VEGAS, Feb. 04, 2025 (GLOBE NEWSWIRE) -- HF Foods Group Inc. (NASDAQ: HFFG) (“HF Foods” or the “Company”), a leading food distributor to Asian restaurants across the United States, announc
Reviva to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference
08:00am, Tuesday, 04'th Feb 2025
CUPERTINO, Calif., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies
Avalo Therapeutics to Present at Oppenheimer's 35th Annual Healthcare Life Sciences Conference
08:00am, Tuesday, 04'th Feb 2025
WAYNE, Pa. and ROCKVILLE, Md. , Feb. 04, 2025 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company focused on the treatment of immune dysregulation, toda
Regulus Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
08:00am, Tuesday, 04'th Feb 2025
SAN DIEGO , Feb. 4, 2025 /PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (the
Corvus Pharmaceuticals to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
08:00am, Tuesday, 04'th Feb 2025
BURLINGAME, Calif., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that members of its leadership team will
I-Mab to Present at Oppenheimer's 35th Annual Healthcare Life Sciences Conference
07:30am, Tuesday, 04'th Feb 2025
ROCKVILLE, Md., Feb. 04, 2025 (GLOBE NEWSWIRE) -- I-Mab (NASDAQ: IMAB) (the Company), a U.S.-based, global biotech company, focused on the development of precision immuno-oncology agents for the treat
Sensei Biotherapeutics to Participate in Oppenheimer's 35th Annual Healthcare Life Sciences Conference
07:30am, Tuesday, 04'th Feb 2025
BOSTON, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage biotechnology company focused on the discovery and development of next-generation therapeutics f
Cardiol Therapeutics to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference
07:27am, Tuesday, 04'th Feb 2025
Toronto, Ontario--(Newsfile Corp. - February 4, 2025) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on the researc
Clearside Biomedical to Participate in Fireside Chat at the Oppenheimer 35th Annual Healthcare Life Sciences Virtual Conference
07:05am, Tuesday, 04'th Feb 2025
ALPHARETTA, Ga., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the
Climb Bio to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
07:00am, Tuesday, 04'th Feb 2025
WELLESLEY, Mass., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM) today announced that members of its executive team will participate at the Oppenheimer 35th Annual Healthcare Life Sc
Nurix Therapeutics to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference
07:00am, Tuesday, 04'th Feb 2025
SAN FRANCISCO, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targ
